Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Researchers find distinct cell receptors with the potential for new treatments.

2.

Biomarker-Selected Treatment Shows Promise for Bladder Preservation in MIBC

3.

Laser Therapy Shows Promise for Brain Tumors

4.

Unified Neuro/Psych Residency Program: New Proposal.

5.

Basal stem-like cells identified as origin of small cell lung cancer in lab models


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot